These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 16429567)
1. Preparation of enantiomers of quinuclidin-3-Ol derivatives and their interactions with human cholinesterases. Simeon-Rudolf V; Tomić S; Bosak A; Primozic I; Orsulić M Chem Biol Interact; 2005 Dec; 157-158():420-1. PubMed ID: 16429567 [No Abstract] [Full Text] [Related]
2. [The difference in the mechanism of irreversible inhibition of cholinesterases from different species]. Rozengart EV; Shestakova NN Dokl Akad Nauk; 1999 Apr; 365(5):697-9. PubMed ID: 10368752 [No Abstract] [Full Text] [Related]
3. [Identification of the metabolites of penehyclidine hydrochloride raceme in rats by LC-MS/MS and ion cluster]. Xue M; Ruan JX; Yuan SL; Zhang ZQ; Qiao JZ; Guo JF Yao Xue Xue Bao; 2002 Oct; 37(10):802-6. PubMed ID: 12567866 [TBL] [Abstract][Full Text] [Related]
4. Preparation of novel meta- and para-substituted N-benzyl protected quinuclidine esters and their resolution with butyrylcholinesterase. Primožič I; Bolant M; Ramić A; Tomić S Molecules; 2012 Jan; 17(1):786-95. PubMed ID: 22249408 [TBL] [Abstract][Full Text] [Related]
5. [About mechanism of interaction of phosphororganic inhibitors with cholinesterases of different origin]. Rozengart EV; Basova NE; Suvorov AA Zh Evol Biokhim Fiziol; 2002; 38(3):208-13. PubMed ID: 12325259 [No Abstract] [Full Text] [Related]
6. Molecular basis of interactions of cholinesterases with tight binding inhibitors. Radić Z; Manetsch R; Krasiński A; Raushel J; Yamauchi J; Garcia C; Kolb H; Sharpless KB; Taylor P Chem Biol Interact; 2005 Dec; 157-158():133-41. PubMed ID: 16289416 [TBL] [Abstract][Full Text] [Related]
7. Interactions of organophosphorus and related compounds with cholinesterases, a theoretical study. Hurley MM; Balboa A; Lushington GH; Guo J Chem Biol Interact; 2005 Dec; 157-158():321-5. PubMed ID: 16289061 [TBL] [Abstract][Full Text] [Related]
8. Alkylammonium derivatives of chlorobenzoic acids: a new group of reversible ester bond-containing inhibitors of cholinesterases of different animals. Basova NE; Rozengart EV Dokl Biochem Biophys; 2005; 402():226-9. PubMed ID: 16116755 [No Abstract] [Full Text] [Related]
9. Novel substituted (Z)-2-(N-benzylindol-3-ylmethylene)quinuclidin-3-one and (Z)-(+/-)-2-(N-benzylindol-3-ylmethylene)quinuclidin-3-ol derivatives as potent thermal sensitizing agents. Sonar VN; Thirupathi Reddy Y; Sekhar KR; Sasi S; Freeman ML; Crooks PA Bioorg Med Chem Lett; 2007 Dec; 17(24):6821-4. PubMed ID: 17980582 [TBL] [Abstract][Full Text] [Related]
10. [Sensitivity of cholinesterases from various sources to organophosphate inhibitors with S-alkyl radicals of various lengths]. Kormilitsyn BN; Moralev SN; Khovanskikh AE; Dalimov DN Zh Evol Biokhim Fiziol; 2003; 39(5):405-9. PubMed ID: 14689726 [No Abstract] [Full Text] [Related]
12. Interaction of cholinesterase from the visual ganglia of the Commander squid Berryteuthis magister from different areas of the range with reversible inhibitors. Rozengart EV; Basova NE Dokl Biochem Biophys; 2009; 428():277-83. PubMed ID: 20848918 [No Abstract] [Full Text] [Related]
13. Coumarins as cholinesterase inhibitors: A review. de Souza LG; Rennã MN; Figueroa-Villar JD Chem Biol Interact; 2016 Jul; 254():11-23. PubMed ID: 27174134 [TBL] [Abstract][Full Text] [Related]
15. Quinuclidin-2-ene-based muscarinic antagonists. Hacksell U; Nilsson BM; Nordvall G; Johansson G; Sundquist S; Nilvebrant L Life Sci; 1995; 56(11-12):831-6. PubMed ID: 10188782 [TBL] [Abstract][Full Text] [Related]
16. Development of acetophenone ligands as potential neuroimaging agents for cholinesterases. Jollymore-Hughes CT; Pottie IR; Martin E; Rosenberry TL; Darvesh S Bioorg Med Chem; 2016 Nov; 24(21):5270-5279. PubMed ID: 27637382 [TBL] [Abstract][Full Text] [Related]
17. [Benzimidazolium derivatives with delocalized charge in the cation group as reversible inhibitors of cholinesterases of different origin]. Rozengart EV; Girshovich MZ; Basova NE Dokl Akad Nauk; 1997 Jul; 355(1):123-5. PubMed ID: 9333408 [No Abstract] [Full Text] [Related]
18. A cascade synthesis, in vitro cholinesterases inhibitory activity and docking studies of novel Tacrine-pyranopyrazole derivatives. Derabli C; Boualia I; Abdelwahab AB; Boulcina R; Bensouici C; Kirsch G; Debache A Bioorg Med Chem Lett; 2018 Aug; 28(14):2481-2484. PubMed ID: 29887354 [TBL] [Abstract][Full Text] [Related]
19. Analysis of cholinesterase inactivation and reactivation by systematic structural modification and enantiomeric selectivity. Taylor P; Wong L; Radić Z; Tsigelny I; Brüggemann R; Hosea NA; Berman HA Chem Biol Interact; 1999 May; 119-120():3-15. PubMed ID: 10421434 [TBL] [Abstract][Full Text] [Related]
20. [Mechanism of competitive and noncompetitive inhibition of cholinesterases of various origin]. Rozengart EV; Shestakova NN; Prokator SO; Basova NE Dokl Akad Nauk; 1999 Jan; 364(2):268-70. PubMed ID: 10188086 [No Abstract] [Full Text] [Related] [Next] [New Search]